认知
生物标志物
认知障碍
医学
磁共振成像
正电子发射断层摄影术
认知测验
内科学
数字聚合酶链反应
睡眠剥夺对认知功能的影响
听力学
认知功能衰退
疾病
接收机工作特性
心理学
认知障碍
肿瘤科
诊断生物标志物
病理
试验预测值
神经心理学
蒙特利尔认知评估
曲线下面积
曲线下面积
诊断准确性
胶质纤维酸性蛋白
作者
Yi Ling,Pan Sun,Chen Wang,Guoping Peng,Yiying Wang,Xin Zhou,Zhengbo He,Binhui Liu,Jie Zhang,Jun Yu,Yujie Su,Kai Li,Tengfei Guo,Benyan Luo
摘要
Abstract INTRODUCTION Detecting and monitoring cognitive performance in older adults is critical. In this study, we evaluated the validity of an eye‐tracking tool in diagnosing cognitive impairment. METHODS We recruited 119 cognitively unimpaired (CU) individuals and 157 cognitively impaired (CI) patients who completed digital eye‐tracking tests and cognitive scales. Of them, 154, 120, 53, and 146 underwent plasma biomarker tests, amyloid‐β positron emission tomography (Aβ‐PET) scans, tau‐PET scans, and magnetic resonance imaging (MRI) scans. The diagnostic performance of eye‐tracking markers and their relationships to Alzheimer's disease biomarkers and cognition were examined. RESULTS The eye‐tracking panel exhibited better performance (area under the curve [AUC] = 0.865) in classifying CI from CU compared to plasma Aβ 42/40 (AUC = 0.699), p‐Tau 217 (AUC = 0.769), p‐Tau 217 /Aβ 42 (AUC = 0.801), glial fibrillary acidic protein (GFAP; AUC = 0.804), and neurofilament light chain (NfL) (AUC = 0.826). DISCUSSION These findings demonstrate the validity of digital eye‐tracking markers for screening patients with cognitive impairment, providing a novel digital marker for detecting cognitive decline in older adults.
科研通智能强力驱动
Strongly Powered by AbleSci AI